|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics. |
BIOCEN |
Registered |
|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics |
BIOCEN |
Registered |
|
2010-12-09 |
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults. |
BIOCEN |
Registered |
|
2010-12-27 |
Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis |
CIM |
Registered |
|
2010-12-27 |
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. |
CIM |
Registered |
|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics |
BIOCEN |
Registered |
|
2010-12-20 |
Dynamic-I |
CIGB |
Registered |
|
2008-10-07 |
FarmaPEG-I |
CIGB |
Registered |
|
2010-12-20 |
Dermosep-I |
CIGB |
Registered |
|
2010-12-20 |
EPANEM-III |
CIGB |
Registered |
|
2010-12-20 |
AntiCEA M3-I |
CIGB |
Registered |
|
2010-06-11 |
Phase I clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
CIGB |
Registered |
|
2008-09-12 |
Tisuacryl® in Dentistry |
BIOMAT |
Registered |
|
2008-09-12 |
Tisuacryl® in esophageal surgery |
BIOMAT |
Registered |
|
2008-09-30 |
Cutaneous Use of Tisuacryl® |
BIOMAT |
Registered |
|
2010-12-24 |
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers. |
CIGB |
Registered |
|
2010-12-24 |
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2). |
CIGB |
Registered |
|
2008-07-29 |
Post marketing clinical trial to evaluate the reactogenicity profile of the Cuban vaccine against diphtheria, tetanus, and pertussis infections in infants. |
FINLAY |
Registered |
|
2009-12-24 |
InCroMiel I |
CIGB |
Registered |
|
2008-09-12 |
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique. |
FINLAY |
Registered |
